358 related articles for article (PubMed ID: 10192339)
1. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
2. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
[TBL] [Abstract][Full Text] [Related]
3. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
[TBL] [Abstract][Full Text] [Related]
4. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
[TBL] [Abstract][Full Text] [Related]
5. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
Kim YH; Martinez G; Varghese A; Hoppe RT
Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
[TBL] [Abstract][Full Text] [Related]
6. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
[TBL] [Abstract][Full Text] [Related]
7. Mycosis fungoides: management with topical nitrogen mustard.
Hoppe RT; Abel EA; Deneau DG; Price NM
J Clin Oncol; 1987 Nov; 5(11):1796-803. PubMed ID: 3681368
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides in young patients: clinical characteristics and outcome.
Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
Kim YH; Chow S; Varghese A; Hoppe RT
Arch Dermatol; 1999 Jan; 135(1):26-32. PubMed ID: 9923777
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy in the management of mycosis fungoides: indications, results, prognosis. Twenty years experience.
Kirova YM; Piedbois Y; Haddad E; Levy E; Calitchi E; Marinello G; Le Bourgeois JP
Radiother Oncol; 1999 May; 51(2):147-51. PubMed ID: 10435806
[TBL] [Abstract][Full Text] [Related]
11. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment.
Jennings T; Duffy R; Gochoco A; Knoblauch K; Shi W; Alpdogan SO; Porcu P; Werner-Wasik M; Sahu J
Chin Clin Oncol; 2019 Feb; 8(1):13. PubMed ID: 30525753
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of mycosis fungoides management by total skin electron beam therapy with "translational technique".
Gamsiz H; Beyzadeoglu M; Sager O; Dincoglan F; Uysal B; Demiral S; Gundem E; Dirican B
J BUON; 2015; 20(4):1124-31. PubMed ID: 26416066
[TBL] [Abstract][Full Text] [Related]
13. Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis.
Lindahl LM; Fenger-Gron M; Iversen L
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):163-8. PubMed ID: 22229501
[TBL] [Abstract][Full Text] [Related]
14. Revisiting low-dose total skin electron beam therapy in mycosis fungoides.
Harrison C; Young J; Navi D; Riaz N; Lingala B; Kim Y; Hoppe R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e651-7. PubMed ID: 21489711
[TBL] [Abstract][Full Text] [Related]
15. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
17. Total Skin Electron Beam Therapy for Mycosis Fungoides Revisited With Adjuvant Systemic Therapy.
Rivers CI; Singh AK
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):83-88. PubMed ID: 30528417
[TBL] [Abstract][Full Text] [Related]
18. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
[TBL] [Abstract][Full Text] [Related]
19. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
[TBL] [Abstract][Full Text] [Related]
20. Management with topical nitrogen mustard in mycosis fungoides.
Kim YH
Dermatol Ther; 2003; 16(4):288-98. PubMed ID: 14686971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
